Dabigatran and Abciximab: Interaction Details
- Dabigatran
- Pradaxa
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dabigatran and Abciximab interaction:
Abciximab
We don't have a drug information page for Abciximab because it is no longer sold in the US: the FDA lists every licensed version as discontinued. Have a question about Abciximab? Ask a pharmacist, free →
What Happens When You Take Dabigatran With Abciximab
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because abciximab, an agent, and exert anticoagulant effects, giving them together may raise the likelihood of major bleeding events.12 In patients who have taken oral anticoagulants in the preceding seven days, abciximab is unless the prothrombin time does not exceed 1.2 times control.1 When an anticoagulant must be used alongside it, patients should be observed for clinical signs and symptoms of bleeding.3
The Dabigatran and Abciximab Interaction, Explained
Dabigatran (Pradaxa) is a that helps prevent clots. Abciximab is a strong medicine given in the hospital, usually during heart procedures, that stops (tiny blood cells) from clumping together. Because both medicines slow down clotting in different ways, using them close together could raise your risk of serious bleeding.
This concern is based on how the drugs work, not on direct studies. Still, it is taken seriously. If you take Pradaxa, make sure your hospital team knows, including when your last dose was. Your care team can plan safely and will watch you closely for any bleeding.
Mechanism: impairment of hemostasis. Dabigatran is a direct thrombin (administered as the dabigatran etexilate, but activation is by esterases, so this does not alter the interaction). Abciximab is a GP IIb/IIIa receptor . No PK interaction is expected.
- Effect: Increased risk of major bleeding. Severity: major. Onset: unspecified.
- Evidence: Theoretical. No specific study data for this pair.
- Labeling: Abciximab is with oral use within 7 days unless PT is no more than 1.2 times control. Note that PT poorly reflects dabigatran activity, so interpret it cautiously.
- Management: Use caution. Determine timing of the last dabigatran dose. If is required, closely monitor for clinical signs and symptoms of bleeding.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dabigatran and Abciximab Interact
The likely mechanism
effect on hemostasis
How to Manage the Dabigatran and Abciximab Interaction
This combination usually comes up in a hospital setting, so your care team will handle most of the planning.
- Your team will check when you last took dabigatran, because abciximab is generally not given within 7 days of an oral unless clotting test results allow it.
- If both are needed, your team will monitor you closely for bleeding.
- Keep taking dabigatran as prescribed, and always tell staff you take it before any procedure.
- Report unusual bruising, blood in urine or stool, nosebleeds, or bleeding that will not stop.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dabigatran or Abciximab need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: XARELTO oral tablets, oral suspension, rivaroxaban oral tablets, oral suspension
Two drug interaction studies evaluated the of clopidogrel ( agent), given as a 300 mg loading dose followed by a 75 mg daily maintenance dose, with rivaroxaban (factor Xa , ) 15 mg as a single dose in healthy subjects. Bleeding time increased to 45 minutes in approximately 45% and 30% of subjects in these studies, respectively.
This change in bleeding time was roughly twice the maximum increase observed with either drug given alone. The of neither drug were altered.3
Dabigatran and Abciximab: Common Questions
How serious is the Dabigatran and Abciximab interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Dabigatran and Abciximab interaction managed?
This combination usually comes up in a hospital setting, so your care team will handle most of the planning. Your team will check when you last took dabigatran, because abciximab is generally not given within 7 days of an oral unless clotting test results allow it. If both are needed, your team will monitor you closely for bleeding. Keep taking dabigatran as prescribed, and always te… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dabigatran and Abciximab Interaction
Ask in your own words about taking Dabigatran and Abciximab together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: REOPRO(R) IV injection, abciximab IV injection. Eli Lilly and Company, Indianapolis, IN, 2005.
- Product Information: LOVENOX(R) solution for subcutaneous and intravenous injection, enoxaparin sodium solution for subcutaneous and intravenous injection. Sanofi-Aventis, Bridgewater, NJ, 2009. DailyMed
- Product Information: XARELTO(R) oral tablets, oral suspension, rivaroxaban oral tablets, oral suspension. Janssen Pharmaceuticals Inc (per FDA), Titusville, NJ, 2023. DailyMed
Other Serious Interactions of Dabigatran and Abciximab
Also serious with Dabigatran
Also serious with Abciximab
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Dabigatran
- St. John's WortMajor
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- + 233 more
With Abciximab
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- CaffeineModerate
- + 215 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.